China, Aug. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study of PCSK9 Inhibitors for Preventing Early Neurological Deterioration in Branch Atheromatous Disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130261
Registration Time: 2026/08/18
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Dalian Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338830
Published by HT Digital Content Services with permission from Health Daily Digest....